Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onder Alpdogan

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Transplantation and Cellular Therapy|July 3, 2026
Harnessing the Power of Two: High-Dose Stem Cell Haploidentical Transplant in Hematologic Malignancies - A Prospective TrialXia Bi, Boula Gattas, Dolores Grosso, et al.
Blood|June 16, 2005
Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviationVanessa M Hubbard, Jeffrey M Eng, Teresa Ramirez-Montagut, et al.
The Journal of Experimental Medicine|July 14, 2004
GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host diseaseStephanie J Muriglan, Teresa Ramirez-Montagut, Onder Alpdogan, et al.
Blood|November 24, 2005
Keratinocyte growth factor (KGF) is required for postnatal thymic regenerationOnder Alpdogan, Vanessa M Hubbard, Odette M Smith, et al.
Nature Medicine|November 12, 2002
T cells require TRAIL for optimal graft-versus-tumor activityCornelius Schmaltz, Onder Alpdogan, Barry J Kappel, et al.
Blood|January 8, 2008
Organ-derived dendritic cells have differential effects on alloreactive T cellsTheo D Kim, Theis H Terwey, Johannes L Zakrzewski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage diseaseDolores Grosso, Sameh Gaballa, Onder Alpdogan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host diseaseTeresa Ramirez-Montagut, Andrew Chow, Adam A Kochman, et al.
Blood Advances|August 2, 2023
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 studyBradley Haverkos, Onder Alpdogan, Robert Baiocchi, et al.
Blood|July 23, 2005
CCR2 is required for CD8-induced graft-versus-host diseaseTheis H Terwey, Theo D Kim, Adam A Kochman, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Transplantation and Cellular Therapy|July 3, 2026
Harnessing the Power of Two: High-Dose Stem Cell Haploidentical Transplant in Hematologic Malignancies - A Prospective TrialXia Bi, Boula Gattas, Dolores Grosso, et al.
Blood|June 16, 2005
Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviationVanessa M Hubbard, Jeffrey M Eng, Teresa Ramirez-Montagut, et al.
The Journal of Experimental Medicine|July 14, 2004
GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host diseaseStephanie J Muriglan, Teresa Ramirez-Montagut, Onder Alpdogan, et al.
Blood|November 24, 2005
Keratinocyte growth factor (KGF) is required for postnatal thymic regenerationOnder Alpdogan, Vanessa M Hubbard, Odette M Smith, et al.
Nature Medicine|November 12, 2002
T cells require TRAIL for optimal graft-versus-tumor activityCornelius Schmaltz, Onder Alpdogan, Barry J Kappel, et al.
Blood|January 8, 2008
Organ-derived dendritic cells have differential effects on alloreactive T cellsTheo D Kim, Theis H Terwey, Johannes L Zakrzewski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage diseaseDolores Grosso, Sameh Gaballa, Onder Alpdogan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host diseaseTeresa Ramirez-Montagut, Andrew Chow, Adam A Kochman, et al.
Blood Advances|August 2, 2023
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 studyBradley Haverkos, Onder Alpdogan, Robert Baiocchi, et al.
Blood|July 23, 2005
CCR2 is required for CD8-induced graft-versus-host diseaseTheis H Terwey, Theo D Kim, Adam A Kochman, et al.
Pageof 9